Innovation for lifeSofinnova

Purpose
People
Portfolio
Platforms
Press

Purpose
People
Portfolio
Platforms
Press
Careers
Contact
Investor Portal

Company — Audentes Therapeutics

October 24, 2017

Share

file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/facebook.svg
file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/linkedin.svg
file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/twitter.svg

New treatments for people with serious, rare diseases through the application of gene therapy technology. (NASDAQ: BOLD) (Acquired by Astellas)

Share

file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/facebook.svg
file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/linkedin.svg
file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/twitter.svg

3000 Sand Hill Rd
Building 3-Suite 150
Menlo Park, CA 94025
(650) 681-8420

One Marina Park Drive
Suite 300
Boston, MA 02210

27 West 24th Street
Suite 302
New York, NY 10010

© 2026 Sofinnova | Privacy Policy